These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 25745051)

  • 1. Discrepant elevation of sIL-2R levels in sarcoidosis patients with renal insufficiency.
    Verwoerd A; Vorselaars AD; van Moorsel CH; Bos WJ; van Velzen-Blad H; Grutters JC
    Eur Respir J; 2015 Jul; 46(1):277-80. PubMed ID: 25745051
    [No Abstract]   [Full Text] [Related]  

  • 2. Correlation of spleen metabolism assessed by 18F-FDG PET with serum interleukin-2 receptor levels and other biomarkers in patients with untreated sarcoidosis.
    Kalkanis A; Kalkanis D; Drougas D; Vavougios GD; Datseris I; Judson MA; Georgiou E
    Nucl Med Commun; 2016 Mar; 37(3):273-7. PubMed ID: 26544095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Value of serum soluble interleukin-2 receptor as a diagnostic and predictive biomarker in sarcoidosis.
    Schimmelpennink MC; Quanjel M; Vorselaars A; Wiertz I; Veltkamp M; Van Moorsel C; Grutters JC
    Expert Rev Respir Med; 2020 Jul; 14(7):749-756. PubMed ID: 32248706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ACE and sIL-2R correlate with lung function improvement in sarcoidosis during methotrexate therapy.
    Vorselaars AD; van Moorsel CH; Zanen P; Ruven HJ; Claessen AM; van Velzen-Blad H; Grutters JC
    Respir Med; 2015 Feb; 109(2):279-85. PubMed ID: 25496652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of relapse after discontinuation of infliximab therapy in severe sarcoidosis.
    Vorselaars AD; Verwoerd A; van Moorsel CH; Keijsers RG; Rijkers GT; Grutters JC
    Eur Respir J; 2014 Feb; 43(2):602-9. PubMed ID: 23988768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reticuloendothelial system involvement in untreated sarcoidosis patients as assessed by 18F-FDG PET scanning.
    Kalkanis A; Judson MA; Kalkanis D; Vavougios GD; Malamitsi J; Georgou E
    Sarcoidosis Vasc Diffuse Lung Dis; 2016 Dec; 33(4):423-425. PubMed ID: 28079858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Serum soluble IL-2 receptor level in patients with sarcoidosis].
    Ina Y; Takada K; Noda M; Satou T; Hashiba H; Miyachi A; Ito S; Iijima N; Yamamoto M
    Nihon Kyobu Shikkan Gakkai Zasshi; 1991 Mar; 29(3):316-21. PubMed ID: 2067152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Systemic sarcoidosis and membranous glomerulonephritis].
    Aydi Z; Ben Dhaou B; Baili L; Daoud F; Ben Moussa F; Boussema F; Rokbani L
    Rev Pneumol Clin; 2014 Dec; 70(6):375-9. PubMed ID: 25459352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chitotriosidase and soluble IL-2 receptor: comparison of two markers of sarcoidosis severity.
    Bargagli E; Bianchi N; Margollicci M; Olivieri C; Luddi A; Coviello G; Grosso S; Rottoli P
    Scand J Clin Lab Invest; 2008; 68(6):479-83. PubMed ID: 18609101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nephrotic syndrome, nephromegaly, renal hyperfiltration, and sudden death in a diabetic woman.
    Am J Med; 1995 Nov; 99(5):563-72. PubMed ID: 7485215
    [No Abstract]   [Full Text] [Related]  

  • 11. Soluble IL-2 receptor in patients with primary nephrotic syndrome.
    Ohno I; Gomi H; Matsuda H; Nakano H; Matsumoto H; Kodama K; Shibasaki T; Ishimoto F; Sakai O
    Nihon Jinzo Gakkai Shi; 1991 May; 33(5):483-9. PubMed ID: 1895547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tiger man sign in sarcoid myopathy.
    Kuzume A; Terao T; Miura D; Takeuchi K; Matsue K
    Rheumatology (Oxford); 2021 Aug; 60(8):3953-3954. PubMed ID: 33367901
    [No Abstract]   [Full Text] [Related]  

  • 13. Soluble interleukin-2 receptors in plasma cell dyscrasias.
    Takamatsu T; Yasuda N; Ohno T; Kanoh T; Uchino H; Fujii H
    Nihon Ketsueki Gakkai Zasshi; 1989 Jul; 52(4):749-55. PubMed ID: 2618549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Membranous nephropathy associated with childhood sarcoidosis.
    Dimitriades C; Shetty AK; Vehaskari M; Craver RD; Gedalia A
    Pediatr Nephrol; 1999 Jun; 13(5):444-7. PubMed ID: 10412867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognosis and risk factors for idiopathic membranous nephropathy with nephrotic syndrome in Japan.
    Shiiki H; Saito T; Nishitani Y; Mitarai T; Yorioka N; Yoshimura A; Yokoyama H; Nishi S; Tomino Y; Kurokawa K; Sakai H;
    Kidney Int; 2004 Apr; 65(4):1400-7. PubMed ID: 15086481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spontaneous remission of nephrotic syndrome in membranous nephropathy with chronic renal impairment.
    Polanco N; Gutiérrez E; Rivera F; Castellanos I; Baltar J; Lorenzo D; Praga M;
    Nephrol Dial Transplant; 2012 Jan; 27(1):231-4. PubMed ID: 21624942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute glomerulonephritis complicating diabetic nephropathy.
    Olivero J; Suki WN
    Arch Intern Med; 1977 Jun; 137(6):732-4. PubMed ID: 869644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of proteinuria on urinary cystatin-C and glomerular filtration rate calculated by serum cystatin-C.
    Kim JS; Kim MK; Lee JY; Han BG; Choi SO; Yang JW
    Ren Fail; 2012; 34(6):676-84. PubMed ID: 22607020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Changes in soluble interleukin-2 receptor and its significance in nephrotic syndrome].
    Zhang DY; Ye RG; Li YJ
    Zhonghua Nei Ke Za Zhi; 1994 May; 33(5):309-12. PubMed ID: 7835141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High serum levels of soluble interleukin-2 receptors in sarcoidosis.
    Semenzato G; Cipriani A; Trentin L; Zambello R; Masciarelli M; Vinante F; Chilosi M; Pizzolo G
    Sarcoidosis; 1987 Mar; 4(1):25-7. PubMed ID: 3108983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.